C. Matthew Peterson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
C. Matthew Peterson has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Douglas T. Carrell
Andrology and IVF Laboratory, Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT 84108, USA
6 shared publications Ahmad O. Hammoud
3 shared publications- Germaine M. Buck Louis
College of Health and Human Services George Mason University Fairfax Virginia USA
3 shared publications - Michael Walter Varner
University of Utah
3 shared publications - Zhen Chen
Biostatistics and Bioinformatics Branch, Division of Population Health Research, Division of Intramural Research Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health Bethesda Maryland USA
3 shared publications Anne Kennedy
2 shared publications
Latest Publications
- Open Access
- 12 November 2019
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 189 (1) , 8-26
A Randomized Trial to Evaluate the Effects of Folic Acid and Zinc Supplementation on Male Fertility and Livebirth: Design and Baseline Characteristics
The Folic Acid and Zinc Supplementation Trial (FAZST) was a multicenter, double-blind, block-randomized, placebo-controlled trial to determine whether folic acid and zinc supplementation in men improves semen quality and increases livebirth rate among couples seeking infertility treatment (2013–2017). Eligible men were aged 18 years or older with female partners aged 18–45 years, seeking infertility treatment. Men were randomized (1:1) to 5 mg folic acid and 30 mg elemental zinc daily or matching placebo for 6 months. Randomization was stratified by site and intended infertility treatment (in vitro fertilization (IVF), non-IVF/study site, and non-IVF/outside clinic). Follow-up of men continued for 6 months, and female partners were passively followed for a minimum of 9 months. Women who conceived were followed throughout pregnancy. Overall, 2,370 men were randomized during 2013–2017 (1,185 folic acid and zinc, 1,185 placebo); they had a mean age of 33 years and body mass index (weight (kg)/height (m)2) of 29.8. Most participants were white (82%), well educated (83% with some college), and employed (72%). Participant characteristics were balanced across intervention arms. Study visits were completed by 89%, 77%, and 75% of men at months 2, 4, and 6, respectively. Here we describe the study design, recruitment, data collection, lessons learned, and baseline participant characteristics.
- 12 November 2019
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 189 (1) , 8-26
Open AccessA Randomized Trial to Evaluate the Effects of Folic Acid and Zinc Supplementation on Male Fertility and Livebirth: Design and Baseline Characteristics
The Folic Acid and Zinc Supplementation Trial (FAZST) was a multicenter, double-blind, block-randomized, placebo-controlled trial to determine whether folic acid and zinc supplementation in men improves semen quality and increases livebirth rate among couples seeking infertility treatment (2013–2017). Eligible men were aged 18 years or older with female partners aged 18–45 years, seeking infertility treatment. Men were randomized (1:1) to 5 mg folic acid and 30 mg elemental zinc daily or matching placebo for 6 months. Randomization was stratified by site and intended infertility treatment (in vitro fertilization (IVF), non-IVF/study site, and non-IVF/outside clinic). Follow-up of men continued for 6 months, and female partners were passively followed for a minimum of 9 months. Women who conceived were followed throughout pregnancy. Overall, 2,370 men were randomized during 2013–2017 (1,185 folic acid and zinc, 1,185 placebo); they had a mean age of 33 years and body mass index (weight (kg)/height (m)2) of 29.8. Most participants were white (82%), well educated (83% with some college), and employed (72%). Participant characteristics were balanced across intervention arms. Study visits were completed by 89%, 77%, and 75% of men at months 2, 4, and 6, respectively. Here we describe the study design, recruitment, data collection, lessons learned, and baseline participant characteristics.
- Top Cited Papers
- 5 November 2016
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 34 (2) , 167-177
Female infertility, infertility-associated diagnoses, and comorbidities: a review
Purpose The purpose of the study is to evaluate existing literature for possible associations between female infertility, infertility-associated diagnoses, and the following areas of disease: psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction. Methods The design of the study is a literature review. The patients were women included in 26 selected studies due to a diagnosis of infertility or a reproductive disorder associated with infertility. This study has no interventions, and the main outcome measure is the association between female infertility or a related diagnosis and psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction. Results Female infertility and related reproductive disorders may have ramifications for women beyond reproductive health. An analysis of publications shows that women with infertility had higher rates of psychiatric disorders and endometrial cancer than the general population [1–10]. Data is conflicting about whether infertile women are at increased risk for breast cancer and ovarian cancer [7, 8, 10–20]. A generalized diagnosis of infertility was not clearly associated with an increased risk of cardiovascular disease or metabolic dysfunction, but women with infertility related to polycystic ovarian syndrome (PCOS) do appear more likely to develop cardiovascular disease and metabolic disorders such as diabetes than the general population [16, 21–26]. Conclusions Female infertility and associated diagnoses have overall health implications. Beyond treatment of patients’ immediate reproductive needs, healthcare professionals must be aware of the broader health impact of specific causes of infertility in order to provide accurate counseling regarding long-term risk.
- 5 November 2016
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 34 (2) , 167-177
Top Cited PapersFemale infertility, infertility-associated diagnoses, and comorbidities: a review
Purpose The purpose of the study is to evaluate existing literature for possible associations between female infertility, infertility-associated diagnoses, and the following areas of disease: psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction. Methods The design of the study is a literature review. The patients were women included in 26 selected studies due to a diagnosis of infertility or a reproductive disorder associated with infertility. This study has no interventions, and the main outcome measure is the association between female infertility or a related diagnosis and psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction. Results Female infertility and related reproductive disorders may have ramifications for women beyond reproductive health. An analysis of publications shows that women with infertility had higher rates of psychiatric disorders and endometrial cancer than the general population [1–10]. Data is conflicting about whether infertile women are at increased risk for breast cancer and ovarian cancer [7, 8, 10–20]. A generalized diagnosis of infertility was not clearly associated with an increased risk of cardiovascular disease or metabolic dysfunction, but women with infertility related to polycystic ovarian syndrome (PCOS) do appear more likely to develop cardiovascular disease and metabolic disorders such as diabetes than the general population [16, 21–26]. Conclusions Female infertility and associated diagnoses have overall health implications. Beyond treatment of patients’ immediate reproductive needs, healthcare professionals must be aware of the broader health impact of specific causes of infertility in order to provide accurate counseling regarding long-term risk.
- 1 June 2013
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 208 (6) , 451.e1-451.e11
Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study
- 1 June 2013
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 208 (6) , 451.e1-451.e11
Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study
- 1 July 2012
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 120 (1) , 104-112
Interrater and Intrarater Reliability in the Diagnosis and Staging of Endometriosis
To estimate the interrater and intrarater reliability of endometriosis diagnosis and severity of disease among gynecologic surgeons viewing operative digital images. The study population comprised a random sample (n=148 [36%]) of women who participated in the Endometriosis: Natural History, Diagnosis and Outcomes study. Four academic expert and four local, specialized expert surgeons reviewed the images, diagnosed the presence or absence of endometriosis for each woman, and rated severity using the revised American Society for Reproductive Medicine (ASRM) criteria. Interrater-level and intrarater-level agreement were calculated for both endometriosis diagnosis and staging. The interrater reliability for endometriosis diagnosis among the eight surgeons was substantial: Fleiss κ=0.69 (95% confidence interval [CI] 0.64–0.74). Surgeons agreed on revised ASRM endometriosis staging criteria after experienced assessment in a majority of cases (mean 61%, range 52–75%) with moderate interrater reliability: Fleiss κ=0.44 (95% CI 0.41–0.47). The intrarater reliability for experienced assessment compared with computer-assisted revised ASRM staging was almost perfect (mean weighted κ=0.95, range 0.89–0.99). Substantial reliability was found for revised ASRM endometriosis diagnosis, whereas moderate reliability was observed for staging. Almost perfect reliability was observed for surgeons' rating of disease severity compared with computerized-assisted, checklist-based staging. Findings suggest that reliability in endometriosis diagnosis is not greatly altered by location or composition of surgeons, supporting the conduct of multisite studies or compilation of endometriosis data across clinical centers. Although surgeons appear to be skilled at assessing endometriosis stage intuitively, how staging of disease burden correlates with clinical outcomes remains to be developed. II
- 1 July 2012
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 120 (1) , 104-112
Interrater and Intrarater Reliability in the Diagnosis and Staging of Endometriosis
To estimate the interrater and intrarater reliability of endometriosis diagnosis and severity of disease among gynecologic surgeons viewing operative digital images. The study population comprised a random sample (n=148 [36%]) of women who participated in the Endometriosis: Natural History, Diagnosis and Outcomes study. Four academic expert and four local, specialized expert surgeons reviewed the images, diagnosed the presence or absence of endometriosis for each woman, and rated severity using the revised American Society for Reproductive Medicine (ASRM) criteria. Interrater-level and intrarater-level agreement were calculated for both endometriosis diagnosis and staging. The interrater reliability for endometriosis diagnosis among the eight surgeons was substantial: Fleiss κ=0.69 (95% confidence interval [CI] 0.64–0.74). Surgeons agreed on revised ASRM endometriosis staging criteria after experienced assessment in a majority of cases (mean 61%, range 52–75%) with moderate interrater reliability: Fleiss κ=0.44 (95% CI 0.41–0.47). The intrarater reliability for experienced assessment compared with computer-assisted revised ASRM staging was almost perfect (mean weighted κ=0.95, range 0.89–0.99). Substantial reliability was found for revised ASRM endometriosis diagnosis, whereas moderate reliability was observed for staging. Almost perfect reliability was observed for surgeons' rating of disease severity compared with computerized-assisted, checklist-based staging. Findings suggest that reliability in endometriosis diagnosis is not greatly altered by location or composition of surgeons, supporting the conduct of multisite studies or compilation of endometriosis data across clinical centers. Although surgeons appear to be skilled at assessing endometriosis stage intuitively, how staging of disease burden correlates with clinical outcomes remains to be developed. II
- 30 April 2011
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 18 (2) , 262-266
Conservative Treatment of a Herlyn-Werner-Wunderlich Müllerian Anomaly Variant, Noncommunicating Hemiuterus with Gartner Duct Pseudocyst
- 30 April 2011
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 18 (2) , 262-266
Conservative Treatment of a Herlyn-Werner-Wunderlich Müllerian Anomaly Variant, Noncommunicating Hemiuterus with Gartner Duct Pseudocyst
- 19 February 2010
- Published by Springer Nature
- p. 781-803
The Environment and Reproduction: Endocrine Disruption, Reproductive Impairment, and Epigenetics
- 19 February 2010
- Published by Springer Nature
- p. 781-803
The Environment and Reproduction: Endocrine Disruption, Reproductive Impairment, and Epigenetics
- 19 February 2010
- Published by Springer Nature
- p. 545-565
Transvaginal Sonography in Reproductive Endocrinology and Infertility
- 19 February 2010
- Published by Springer Nature
- p. 545-565
Transvaginal Sonography in Reproductive Endocrinology and Infertility
- 19 February 2010
- Published by Springer Nature
- p. 7-37
Assisted Reproductive Technology Practice Management
- 19 February 2010
- Published by Springer Nature
- p. 7-37
Assisted Reproductive Technology Practice Management
- 19 February 2010
- Published by Springer Nature
- p. 265-280
Müllerian (Paramesonephric) Anomalies and Associated Wolffian (Mesonephric) Duct Malformations
- 19 February 2010
- Published by Springer Nature
- p. 265-280
Müllerian (Paramesonephric) Anomalies and Associated Wolffian (Mesonephric) Duct Malformations
- 19 February 2010
- Published by Springer Nature
- p. 209-234
Common Endocrinopathies in Reproductive Endocrinology
- 19 February 2010
- Published by Springer Nature
- p. 209-234
Common Endocrinopathies in Reproductive Endocrinology